Ionis shares phase 3 results for olezarsen in moderate hypertriglyceridaemia
21st May 2025 Uncategorised 0
The drug was recently approved in the US for familial chylomicronaemia syndrome

More: Ionis shares phase 3 results for olezarsen in moderate hypertriglyceridaemia
Source: News
